Miyagawa H, Okada C, Sugiyama H, Hopp R J, Agrawal D K, Nabe M, Gordy C, Bewtra A K, Townley R G
Allergic Disease Center, Creighton University School of Medicine, Omaha, Nebr.
Int Arch Allergy Appl Immunol. 1990;93(1):8-13. doi: 10.1159/000235272.
We investigated the density distribution of neutrophils in peripheral blood of allergic subjects. We divided neutrophils into four groups: fraction 1 (density greater than 1.085), fraction 2 (1.081 less than density less than or equal to 1.085), fraction 3 (1.077 less than density less than or equal to 1.081) and fraction 4 (density less than or equal to 1.077). The percentage of neutrophils in fraction 2 in allergic rhinitis (AR) subjects or asthmatics was lower than that in normals (p less than 0.01). The percentage of neutrophils in fraction 3 and fraction 4 from AR or asthmatics was greater than that in normals (fraction 3, p less than 0.01; fraction 4, p less than 0.05). In neutrophils from AR subjects (fraction 3), chemotaxis to N-formyl-methionyl-leucyl-phenylalanine or platelet-activating factor (PAF) was enhanced compared to fraction 2. PAF (10(-7) M) changed the density of neutrophils (p less than 0.01), which were inhibited by WEB 2086 (p less than 0.05). Furthermore, granulocyte-macrophage colony-stimulating factor changed the density of neutrophils (p less than 0.01). These findings suggest that biological agents may activate neutrophils and convert their density resulting in neutrophils with lower density in allergic subjects.
我们研究了过敏受试者外周血中中性粒细胞的密度分布。我们将中性粒细胞分为四组:组分1(密度大于1.085)、组分2(密度大于1.081且小于或等于1.085)、组分3(密度大于1.077且小于或等于1.081)和组分4(密度小于或等于1.077)。变应性鼻炎(AR)患者或哮喘患者中组分2的中性粒细胞百分比低于正常受试者(p<0.01)。AR患者或哮喘患者中组分3和组分4的中性粒细胞百分比高于正常受试者(组分3,p<0.01;组分4,p<0.05)。与组分2相比,AR患者的中性粒细胞(组分3)对N-甲酰甲硫氨酰亮氨酰苯丙氨酸或血小板活化因子(PAF)的趋化性增强。PAF(10⁻⁷ M)改变了中性粒细胞的密度(p<0.01),而WEB 2086可抑制这种改变(p<0.05)。此外,粒细胞-巨噬细胞集落刺激因子改变了中性粒细胞的密度(p<0.01)。这些发现表明,生物制剂可能激活中性粒细胞并改变其密度,导致过敏受试者中出现密度较低的中性粒细胞。